What life sciences companies need to know about NIST’s new AI guidance


The National Institute of Standards and Technology (NIST) last week released four new documents on artificial intelligence, mostly focusing on generative AI (GAI). The documents seek to both expand NIST’s existing frameworks to directly address the unique aspects of GAI and outline the novel questions still to be addressed in this field. NIST’s work is also likely to affect FDA’s future policymaking efforts in this space.

Fill out the form to read the full article.

Required *

Copy link
Powered by Social Snap